Please Wait
Applying Filters...
menu
    • menu
    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    Sigma-Aldrich empowers scientific discovery with top-quality solutions to accelerate research, innovation, and better health worldwide.

    Virtual Booth

    Contact Supplier

    Athena Pharmaceutiques is a Partner of Choice for Drug Delivery & Life Cycle Management.

    Virtual Booth

    Contact Supplier

    TransoPharm USA works in the Sourcing and Management of Active Pharmaceutical Ingredients.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    An Enquiry

    Menu

    Annamycin

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Physicians Strongly Favor Moleculin's Annamycin for Relapsed AML
    Physicians Strongly Favor Moleculin's Annamycin for Relapsed AML

    05 Jun 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/06/05/3307353/0/en/independent-market-research-finds-strong-physician-intent-to-prescribe-moleculin-s-annamycin-in-relapsed-refractory-aml.html

    GLOBENEWSWIRE
    05 Jun 2026
    Share Share
    Moleculin CEO Highlights 45-Subject Enrollment in Investor Video
    Moleculin CEO Highlights 45-Subject Enrollment in Investor Video

    04 Jun 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/06/04/3306760/0/en/moleculin-ceo-walter-klemp-highlights-45-subject-enrollment-milestone-in-recent-virtual-investor-what-this-means-segment.html

    GLOBENEWSWIRE
    04 Jun 2026
    Share Share
    Moleculin: Annamycin Shows No Cardiotoxicity at High Doses
    Moleculin: Annamycin Shows No Cardiotoxicity at High Doses

    29 May 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/05/29/3303566/0/en/moleculin-presents-asco-2026-data-demonstrating-no-detectable-cardiotoxicity-with-annamycin-despite-exposure-levels-far-exceeding-conventional-anthracycline-limits.html

    GLOBENEWSWIRE
    29 May 2026
    Share Share
    Moleculin Will Present Annamycin Safety Data at ASCO 2026
    Moleculin Will Present Annamycin Safety Data at ASCO 2026

    21 May 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/05/21/3299792/0/en/moleculin-highlights-abstract-accepted-for-poster-presentation-at-the-2026-asco-annual-meeting-highlighting-cardiac-safety-data-for-annamycin.html

    GLOBENEWSWIRE
    21 May 2026
    Share Share
    Moleculin To Unblind MIRACLE Trial With Exceptional Results
    Moleculin To Unblind MIRACLE Trial With Exceptional Results

    13 May 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/05/13/3293939/0/en/moleculin-announces-imminent-miracle-trial-unblinding-as-blinded-data-continue-to-significantly-outperform-historical-benchmarks.html

    GLOBENEWSWIRE
    13 May 2026
    Share Share
    Cleveland Clinic Review: Moleculin's Annamycin Safe In R/R AML
    Cleveland Clinic Review: Moleculin's Annamycin Safe In R/R AML

    12 May 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/05/12/3293002/0/en/independent-cleveland-clinic-review-finds-no-clinically-significant-cardiotoxicity-with-moleculin-s-annamycin-in-r-r-aml-patients-dosed-beyond-conventional-anthracycline-limits.html

    GLOBENEWSWIRE
    12 May 2026
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.